[Medlife]3-Deazaneplanocin A (DZNep) hydrochloride|120964-45-6
简介:3-Deazaneplanocin A hydrochloride 是一种有效的组蛋白甲基转移酶 (EZH2) 抑制剂。
3-去氮腺嘌呤A物理化学性质:
熔点 | 168-169℃ |
---|---|
分子式 | C12H15ClN4O3 |
分子量 | 298.725 |
精确质量 | 298.083282 |
PSA | 117.42000 |
LogP | 0.59190 |
外观性状 | white to beige |
储存条件 | ?20°C |
水溶解性 | H2O: ≥5mg/mL |
3-去氮腺嘌呤A详细介绍:
中文名称: | 3-Deazaneplanocin A |
中文别名: | 3-去氮腺嘌呤A;(1S,2R,5R)-5-(4-氨基-1H-咪唑并[4,5-c]吡啶-1-基)-3-(羟基甲基)-3-环戊烯-1,2-二醇盐酸盐 |
英文名称: | 3-Deazaneplanocin A hydrochloride |
英文别名: | 3-Cyclopentene-1,2-diol, 5-(4-amino-1H-imidazo[4,5-c]pyridin-1-yl)-3-(hydroxymethyl)-, hydrochloride (1:1), (1S,2R,5R)-;3-Deazaneplanocin A Hydrochloride;3-Deazaneplanocin A;3-deazaneplanocin A (DZNeP) HCl;3-Deazaneplanocin A (hydrochloride);3-DEAZANEPLANOCIN HCL;3-Deazaneplanocin hydrochloride;CS-0870;HY-12186;NSC 617989 hydrochloride;SureCN4304150;(-)-1-[(1R,4R,5S)-3-(Hydroxymethyl)-4,5-dihydroxy-2-cyclopenten-1-yl]4-aminoimidazo[4,5-c]pyridine hydrochloride;DZNep hydrochloride;1H-Imidazo[4,5-c]pyridine, 3-cyclopentene-1,2-diol deriv.;NSC 617989 HCl;3-deazaneplanocin A HCl;Histone Methyltransferase EZH2 Inhibitor, DZNep;DZNep;3-Deazaneplanocin A (DZNep) hydrochloride;3-Deazaneplanocin, HCl salt;C12H14N4O3.ClH;2161AH;s7120;A13947;(1S,2R,5R)-5-(4-Amino-1H-imidazo[4,5-c]pyridin-1-yl)-3-(hydroxymethyl)cyclopent-3-e |
CAS号: | 120964-45-6 |
分子式: | C12H15CLN4O3 |
分子量: | 298.73 |
详细描述 | Medlife,致力于提供高品质、高性价比小分子化合物的产品。Medlife小分子化合物大量库存,提供超过2万种的抑制剂、激动剂、拮抗剂等产品,是药物及疾病研究的重要原料供应商。SAHH和EZH2抑制剂,3-Deazaneplanocin A hydrochloride 是一种有效的组蛋白甲基转移酶 (EZH2) 抑制剂。 |
3-去氮腺嘌呤A参考文献:
[1]. Fiskus W, et al. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood, 2009, 114(13), 2733-2743.
[2]. Avan A, et al. Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells. Mol Cancer Ther. 2012 Aug;11(8):1735-46.
[3]. Kikuchi J, et al. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells. Lung Cancer. 2012 Nov;78(2):138-43.
[4]. Sun F, et al. Preclinical pharmacokinetic studies of 3-deazaneplanocin A, a potent epigenetic anticancer agent, and its human pharmacokinetic prediction using GastroPlus?. Eur J Pharm Sci. 2015 Sep 18;77:290-302.
Medlife品牌是国内知名的小分子化合物品牌,致力于信号通路、抑制剂、激动剂等产品的研发及产品供应服务,同时还可提供重组蛋白、植提、寡核苷酸等系列的产品。
本文引用地址:https://www.canspec.cn/product/897568.html